These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 36018150)

  • 1. Combined cell-based therapy strategies for the treatment of Parkinson's disease: focus on mesenchymal stromal cells.
    Rodríguez-Pallares J; García-Garrote M; Parga JA; Labandeira-García JL
    Neural Regen Res; 2023 Mar; 18(3):478-484. PubMed ID: 36018150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glial cell line-derived neurotrophic factor improves intrastriatal graft survival of stored dopaminergic cells.
    Apostolides C; Sanford E; Hong M; Mendez I
    Neuroscience; 1998 Mar; 83(2):363-72. PubMed ID: 9460746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased survival of dopaminergic neurons in striatal grafts of fetal ventral mesencephalic cells exposed to neurotrophin-3 or glial cell line-derived neurotrophic factor.
    Espejo M; Cutillas B; Arenas TE; Ambrosio S
    Cell Transplant; 2000; 9(1):45-53. PubMed ID: 10784066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-dependent effect of mesenchymal stromal cells co-grafted with dopaminergic neurons in a Parkinson's disease rat model.
    Rodriguez-Pallares J; Garcia-Garrote M; Parga JA; Labandeira-Garcia JL
    J Cell Mol Med; 2021 Oct; 25(20):9884-9889. PubMed ID: 34535974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The therapeutic potential of neurotrophic factors in the treatment of Parkinson's disease.
    Lindsay RM; Altar CA; Cedarbaum JM; Hyman C; Wiegand SJ
    Exp Neurol; 1993 Nov; 124(1):103-18. PubMed ID: 8282068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease.
    Kordower JH; Freeman TB; Snow BJ; Vingerhoets FJ; Mufson EJ; Sanberg PR; Hauser RA; Smith DA; Nauert GM; Perl DP
    N Engl J Med; 1995 Apr; 332(17):1118-24. PubMed ID: 7700284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Embryonic stem cell-derived L1 overexpressing neural aggregates enhance recovery in Parkinsonian mice.
    Cui YF; Hargus G; Xu JC; Schmid JS; Shen YQ; Glatzel M; Schachner M; Bernreuther C
    Brain; 2010 Jan; 133(Pt 1):189-204. PubMed ID: 19995872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary tissue for cellular brain repair in Parkinson's disease: Promise, problems and the potential of biomaterials.
    Moriarty N; Parish CL; Dowd E
    Eur J Neurosci; 2019 Feb; 49(4):472-486. PubMed ID: 29923311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stem cell treatment for Parkinson's disease: an update for 2005.
    Snyder BJ; Olanow CW
    Curr Opin Neurol; 2005 Aug; 18(4):376-85. PubMed ID: 16003112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for target-specific nerve fiber outgrowth from subpopulations of grafted dopaminergic neurons: a retrograde tracing study using in oculo and intracranial grafting.
    Törnqvist N; Björklund L; Strömberg I
    Exp Neurol; 2001 Jun; 169(2):329-39. PubMed ID: 11358446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulating Microglia/Macrophage Activation by CDNF Promotes Transplantation of Fetal Ventral Mesencephalic Graft Survival and Function in a Hemiparkinsonian Rat Model.
    Tseng KY; Wu JS; Chen YH; Airavaara M; Cheng CY; Ma KH
    Biomedicines; 2022 Jun; 10(6):. PubMed ID: 35740467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A glial cell line-derived neurotrophic factor-secreting clone of the Schwann cell line SCTM41 enhances survival and fiber outgrowth from embryonic nigral neurons grafted to the striatum and to the lesioned substantia nigra.
    Wilby MJ; Sinclair SR; Muir EM; Zietlow R; Adcock KH; Horellou P; Rogers JH; Dunnett SB; Fawcett JW
    J Neurosci; 1999 Mar; 19(6):2301-12. PubMed ID: 10066280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Embryonic ventral mesencephalic grafts to the substantia nigra of MPTP-treated monkeys: feasibility relevant to multiple-target grafting as a therapy for Parkinson's disease.
    Collier TJ; Sortwell CE; Elsworth JD; Taylor JR; Roth RH; Sladek JR; Redmond DE
    J Comp Neurol; 2002 Jan; 442(4):320-30. PubMed ID: 11793337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flunarizine improves the survival of grafted dopaminergic neurons.
    Kaminski Schierle GS; Hansson O; Brundin P
    Neuroscience; 1999; 94(1):17-20. PubMed ID: 10613492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glial cell line-derived neurotrophic factor increases survival, growth and function of intrastriatal fetal nigral dopaminergic grafts.
    Rosenblad C; Martinez-Serrano A; Björklund A
    Neuroscience; 1996 Dec; 75(4):979-85. PubMed ID: 8938733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The potential of bone morphogenetic protein 2 as a neurotrophic factor for Parkinson's disease.
    Goulding SR; Sullivan AM; O'Keeffe GW; Collins LM
    Neural Regen Res; 2020 Aug; 15(8):1432-1436. PubMed ID: 31997802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-grafted embryonic striatum increases the survival of grafted embryonic dopamine neurons.
    Sortwell CE; Collier TJ; Sladek JR
    J Comp Neurol; 1998 Oct; 399(4):530-40. PubMed ID: 9741481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Astrocytes promote or impair the survival and function of embryonic ventral mesencephalon co-grafts: effects of astrocyte age and expression of recombinant brain-derived neurotrophic factor.
    Krobert K; Lopez-Colberg I; Cunningham LA
    Exp Neurol; 1997 Jun; 145(2 Pt 1):511-23. PubMed ID: 9217087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Embryonic and adult stem cells as a source for cell therapy in Parkinson's disease.
    Levy YS; Stroomza M; Melamed E; Offen D
    J Mol Neurosci; 2004; 24(3):353-86. PubMed ID: 15655260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implanted reuptake-deficient or wild-type dopaminergic neurons improve ON L-dopa dyskinesias without OFF-dyskinesias in a rat model of Parkinson's disease.
    Vinuela A; Hallett PJ; Reske-Nielsen C; Patterson M; Sotnikova TD; Caron MG; Gainetdinov RR; Isacson O
    Brain; 2008 Dec; 131(Pt 12):3361-79. PubMed ID: 18988638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.